Previous Close | 95.86 |
Open | 95.90 |
Bid | 96.60 x 20000 |
Ask | 97.40 x 20000 |
Day's Range | 95.86 - 95.90 |
52 Week Range | 73.08 - 106.30 |
Volume | |
Avg. Volume | 32 |
Market Cap | 23.846B |
Beta (5Y Monthly) | 0.70 |
PE Ratio (TTM) | 41.04 |
EPS (TTM) | 2.36 |
Earnings Date | May 02, 2024 |
Forward Dividend & Yield | 1.88 (1.96%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | 57.92 |
The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer. The U.S. Food and Drug Administration in 2023 recommended against the use of some China-made syringes as it investigated reports of leaks, breakages and other quality problems with such products and last month expanded the guidance. Cardinal did not immediately respond to a Reuters request for comment.
Super Micro Computer's (SMCI) third-quarter fiscal 2024 performance will likely reflect strength in the Server & Storage Systems and Subsystems & Accessories segments.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.